These molecular profiles for SP-resistant Plasmodium population in Myanmar should be underscored in that mutations in dhfr and dhps conferring SP resistance to both P. falciparum and P. vivax were still highly preserved in the parasite population of Myanmar, albeit antifolate drugs were not used for malaria treatment in recent few decades. This evidence concerns the gene DHFR and malaria.